Ali Bazarbachi is a Professor of medicine, the Associate Dean for Basic Research, and the Director of the Bone Marrow Transplantation program at the American University of Beirut-Medical Center. He received his medical degree after residency and fellowship training and a Ph.D. degree from the University of Paris VII in France. His major clinical interest is targeted therapy of hematological malignancies and the use of stem cells for regenerative medicine and bone marrow transplantation. His research focuses on developing oncogene-targeted therapies for leukemia and lymphoma using the HTLV-I-associated adult T cell leukemia/lymphoma as a model. His laboratory is also concerned with the role of angiogenesis in tumor cell extravasation, invasion, and metastasis of human malignancies and in the use of bone marrow-derived mesenchymal stem cells in regenerative medicine. He has held several extramural research grants and has coauthored more than hundred articles in leading scientific journals including The New England Journal of Medicine, Science, The Lancet Oncology, Journal of Clinical Oncology, Blood, Oncogene, and Cancer Research, and he serves as a reviewer for many of these journals. He has delivered several lectures at local, national, and international conferences and symposia as an invited speaker. He received the French National Academy of Medicine Prize, the French National Prize for Cancer Research, the Hafez Kobeissi Prize for Excellence in Scientific Research, the Erwin Diwan award, and the CEDRE award. He is the past President of the Lebanese Society of Hematology.
Biography Updated on 29 June 2010